Literature DB >> 3418851

The medical care cost of human immunodeficiency virus-infected children in Harlem.

J D Hegarty1, E J Abrams, V E Hutchinson, S W Nicholas, M S Suarez, M C Heagarty.   

Abstract

To estimate the cost of hospital care for children infected with the human immunodeficiency virus (n = 37) at Harlem Hospital Center, New York, a cost-based inventory of medical resource consumption was developed. Six thousand thirty-five inpatient days were audited by retrospective chart review. The total cost of care between 1981 and 1986 was +3,362,597. Average lifetime costs were +90,347 per child. One third of the total inpatient days and over 20% of the cost resulted from social rather than medical factors. Per diem costs were highest for children with opportunistic infections (+705) and lowest for homeless "boarder babies" (+466). Boarder babies had a mean length of stay nearly four times longer than those with homes (339 days vs 89 days). The primary predictors of length of stay were maternal intravenous drug use and boarder baby status, regardless of medical need. The unique needs of human immunodeficiency virus-infected children require innovative medical, social, and financial solutions.

Entities:  

Mesh:

Year:  1988        PMID: 3418851

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Boarder babies with AIDS in harlem: lessons in applied public health.

Authors:  Stephen W Nicholas; Elaine J Abrams
Journal:  Am J Public Health       Date:  2002-02       Impact factor: 9.308

2.  Access to prenatal HIV testing.

Authors:  R S Remis; D M Patrick
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

3.  Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.

Authors:  E J Beck; S Mandalia; R Griffith; J Beecham; M D Walters; M Boulton; D L Miller
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 4.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

Review 5.  Economic issues in the prevention of vertical transmission of HIV.

Authors:  A E Ades; J Ratcliffe; D M Gibb; M J Sculpher
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

6.  The effect of prophylaxis on pediatric HIV costs.

Authors:  Leslie S Wilson; Lori Hensic; Carly J Paoli; Rituparna Basu; Maria Christenson; Judith T Moskowitz; Diane Wara
Journal:  AIDS Care       Date:  2011-07-25

7.  The impact of HIV-related illness on employment.

Authors:  E H Yelin; R M Greenblatt; H Hollander; J R McMaster
Journal:  Am J Public Health       Date:  1991-01       Impact factor: 9.308

8.  Results of the ACSUS for pediatric AIDS patients: utilization of services, functional status, and social severity.

Authors:  M C Fahs; D Waite; M Sesholtz; C Muller; E A Hintz; C Maffeo; P Arno; C Bennett
Journal:  Health Serv Res       Date:  1994-12       Impact factor: 3.402

9.  New Jersey's Medicaid waiver for acquired immunodeficiency syndrome.

Authors:  C Merzel; S Crystal; U Sambamoorthi; D Karus; C Kurland
Journal:  Health Care Financ Rev       Date:  1992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.